PDCD1 and cancer: Additional areas of further study with PD-1 inhibitor therapy among patients with advanced cancer to further improve outcomes also include those seeking to elucidate genomic information/biomarkers that may identify more effective novel treatment approaches including PD-1 inhibitor-based combinations, as well as the optimal sequence and duration of treatment.